These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31625346)

  • 1. Does Ruocco's hypothesis on immunocompromised cutaneous area potentiate the early surgical removal of cutaneous benign lesions as adequate prevention?
    Tchernev G; Temelkova I
    J Biol Regul Homeost Agents; 2019; 33(6):1811-1813. PubMed ID: 31625346
    [No Abstract]   [Full Text] [Related]  

  • 2. Eczema of recipient and donor skin graft sites: Another example of "Ruocco's immunocompromised district".
    Verma SB; Wollina U; Ruocco E; Ruocco V
    Dermatol Ther; 2019 Nov; 32(6):e13076. PubMed ID: 31452287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruocco's immunocompromised cutaneous district.
    Piccolo V; Baroni A; Russo T; Schwartz RA
    Int J Dermatol; 2016 Feb; 55(2):135-41. PubMed ID: 26475059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrobiosis lipoidica developing within a surgical scar in a non-diabetic patient: Type III Koebner phenomenon (isomorphic response), Wolf's isotopic response or Ruocco's immunocompromised cutaneous district?
    Prieto-Torres L; Bernárdez C; Hernández-Ostiz S; Pastushenko I; Ara-Martin M; Requena L
    Indian J Dermatol Venereol Leprol; 2017; 83(2):233-236. PubMed ID: 28071608
    [No Abstract]   [Full Text] [Related]  

  • 5. Post skin graft eczematous dermatitis at the donor and recipient sites: a case of Ruocco's immunocompromised district.
    Kulkarni S; Adya KA; Inamadar A
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37524508
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpes zoster occurring over the site of tinea cruris-A case report based on the model of T-cell exhaustion in the Ruocco's immunocompromised cutaneous district.
    Mathur M; Thakur N; Jaiswal S; Maharjan S; Paudel S; Shrestha A
    Clin Case Rep; 2023 Oct; 11(10):e8067. PubMed ID: 37867546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sarcoidal granuloma: A unifying hypothesis for an enigmatic response.
    Mahony J; Helms SE; Brodell RT
    Clin Dermatol; 2014; 32(5):654-9. PubMed ID: 25160107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocompromised Districts of Skin: A Case Series and a Literature Review.
    Vojvodic A; Tirant M; Nardo VD; Lotti T; Wollina U
    Open Access Maced J Med Sci; 2019 Sep; 7(18):2969-2975. PubMed ID: 31850101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocompromised cutaneous district, isotopic, and isopathic phenomena-Systematic review.
    Tabosa GVBS; Stelini RF; Souza EM; Velho PENF; Cintra ML; Florence MEB
    J Cosmet Dermatol; 2021 Feb; 20(2):410-416. PubMed ID: 32629542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinea Confined to Tattoo Sites - An Example of Ruocco's Immunocompromised District.
    Verma SB
    Indian Dermatol Online J; 2019; 10(6):739-740. PubMed ID: 31807466
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management.
    Nucci M; Anaissie E
    Clin Infect Dis; 2002 Oct; 35(8):909-20. PubMed ID: 12355377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease.
    Blokx WA; Andriessen MP; van Hamersvelt HW; van Krieken JH
    Am J Dermatopathol; 2002 Oct; 24(5):414-22. PubMed ID: 12357204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puffy Foot Syndrome: An Important Often Overlooked Clinical Entity.
    Desai AD; Kapila R; Schwartz RA
    Acta Dermatovenerol Croat; 2021 Nov; 29(4):211-214. PubMed ID: 36896692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5% cream for the treatment of cutaneous lesions in immunocompromised patients.
    Johnson R; Stockfleth E
    Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):23-7. PubMed ID: 14606279
    [No Abstract]   [Full Text] [Related]  

  • 15. Ablation of cutaneous lesions using an erbium:YAG laser.
    Khatri KA
    J Cosmet Laser Ther; 2003 Dec; 5(3-4):150-3. PubMed ID: 14741818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic infections in the immunocompromised (non-HIV) host.
    Lopez FA; Sanders CV
    Infect Dis Clin North Am; 2001 Jun; 15(2):671-702, xi. PubMed ID: 11447714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic microcystic adnexal carcinoma in an immunocompromised patient.
    Carroll P; Goldstein GD; Brown CW
    Dermatol Surg; 2000 Jun; 26(6):531-4. PubMed ID: 10848932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunocompromised cutaneous district and the necessity of a new classification of its disparate causes.
    Caccavale S; Kannangara AP; Ruocco E
    Indian J Dermatol Venereol Leprol; 2016; 82(2):227-9. PubMed ID: 26924409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Granulomatous skin disease in an immunocompromised child].
    Boudart J; Fink W; Theunis A; Dangoisse C; Ferster A; André J
    Ann Dermatol Venereol; 2011 Jan; 138(1):38-41. PubMed ID: 21276460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous horns: review of literature and case report.
    Hoffman PC; Lenet MD; Sherman M
    J Foot Surg; 1988; 27(2):130-3. PubMed ID: 3286742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.